306 related articles for article (PubMed ID: 31368152)
1. EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells.
Zheng M; Cao MX; Luo XJ; Li L; Wang K; Wang SS; Wang HF; Tang YJ; Tang YL; Liang XH
J Cell Mol Med; 2019 Oct; 23(10):6942-6954. PubMed ID: 31368152
[TBL] [Abstract][Full Text] [Related]
2. Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion.
Wang Y; Guo W; Li Z; Wu Y; Jing C; Ren Y; Zhao M; Kong L; Zhang C; Dong J; Shuang Y; Sun S; Chen J; Wu C; Qiao Y; Qu X; Wang X; Zhang L; Jin R; Zhou X
Int J Oncol; 2018 Apr; 52(4):1149-1164. PubMed ID: 29532870
[TBL] [Abstract][Full Text] [Related]
3. LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation.
Yu Q; Du Y; Wang S; Zheng X
J Biochem; 2021 Sep; 169(6):721-730. PubMed ID: 33725092
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
Hong Y; He H; Sui W; Zhang J; Zhang S; Yang D
Int J Oncol; 2018 Mar; 52(3):901-912. PubMed ID: 29344674
[TBL] [Abstract][Full Text] [Related]
5. Role of EZH2 in oral squamous cell carcinoma carcinogenesis.
Zhao L; Yu Y; Wu J; Bai J; Zhao Y; Li C; Sun W; Wang X
Gene; 2014 Mar; 537(2):197-202. PubMed ID: 24424512
[TBL] [Abstract][Full Text] [Related]
6. Genistein nanoformulation promotes selective apoptosis in oral squamous cell carcinoma through repression of 3PK-EZH2 signalling pathway.
Dev A; Sardoiwala MN; Kushwaha AC; Karmakar S; Choudhury SR
Phytomedicine; 2021 Jan; 80():153386. PubMed ID: 33113500
[TBL] [Abstract][Full Text] [Related]
7. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
[TBL] [Abstract][Full Text] [Related]
8. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
[TBL] [Abstract][Full Text] [Related]
9. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X
Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422
[TBL] [Abstract][Full Text] [Related]
10. miR‑144‑3p inhibits tumor cell growth and invasion in oral squamous cell carcinoma through the downregulation of the oncogenic gene, EZH2.
He L; Liao L; Du L
Int J Mol Med; 2020 Aug; 46(2):828-838. PubMed ID: 32626925
[TBL] [Abstract][Full Text] [Related]
11. EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia.
Cao W; Younis RH; Li J; Chen H; Xia R; Mao L; Chen W; Ren H
Cancer Prev Res (Phila); 2011 Nov; 4(11):1816-24. PubMed ID: 21697275
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-22 promotes the migration and invasion of oral squamous cell carcinoma cells.
Komine-Aizawa S; Aizawa S; Takano C; Hayakawa S
Immunol Med; 2020 Sep; 43(3):121-129. PubMed ID: 32546118
[TBL] [Abstract][Full Text] [Related]
13. Scutellarein induces apoptosis and inhibits proliferation, migration, and invasion in ovarian cancer via inhibition of EZH2/FOXO1 signaling.
Lang X; Chen Z; Yang X; Yan Q; Xu M; Liu W; He Q; Zhang Y; Cheng W; Zhao W
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22870. PubMed ID: 34350670
[TBL] [Abstract][Full Text] [Related]
14. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells.
Zhang E; Liu S; Xu Z; Huang S; Tan X; Sun C; Lu L
Tumour Biol; 2014 Sep; 35(9):8801-11. PubMed ID: 24879625
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
[TBL] [Abstract][Full Text] [Related]
16. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
17. EZH2 promotes invasion and metastasis of laryngeal squamous cells carcinoma via epithelial-mesenchymal transition through H3K27me3.
Luo H; Jiang Y; Ma S; Chang H; Yi C; Cao H; Gao Y; Guo H; Hou J; Yan J; Sheng Y; Ren X
Biochem Biophys Res Commun; 2016 Oct; 479(2):253-259. PubMed ID: 27638307
[TBL] [Abstract][Full Text] [Related]
18. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the Treatment of Oral Squamous Cell Carcinoma.
Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R
Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760
[TBL] [Abstract][Full Text] [Related]
20. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
Liu X; Fu Y; Huang J; Wu M; Zhang Z; Xu R; Zhang P; Zhao S; Liu L; Jiang H
J Exp Clin Cancer Res; 2019 Jul; 38(1):315. PubMed ID: 31315644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
